Siderosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Siderosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07098650

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

Haemdall: Using Medical Imaging to measure Brain Iron in Superficial Siderosis. This study is looking at a new way of using MRI scans to potentially measure th…

United Kingdom50 participantsStarted 2025-08-14

All recent trials (22 shown)

CompletedNot Applicable

NCT03889132

Glucose, Brain and Microbiota

The accumulation of iron is known to affect the functions of the liver, adipose tissue and muscle. The brain is a well-known place of iron deposition, which is…

Spain128 participantsStarted 2019-03-05

Treatment: Bariatric Surgery

CompletedNot Applicable

NCT03464344

Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in the elderly with high risk of recurrence. The investigators aim t…

France170 participantsStarted 2018-10-12

Treatment: neurological, neuropsychological and MRI evaluation

Siderosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

All recent trials (22 shown)

Glucose, Brain and Microbiota

Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

All recent trials (22 shown)

Glucose, Brain and Microbiota

Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

High Frequency Imaging in Cerebral Amyloid Angiopathy

Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity

Audiovestibular Function in Infratentorial Superficial Siderosis

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients

Iron Deposits in the Pancreas by MRI Method of Dialysis Patients With Hemosiderosis Iatrogenic (ERDFP)

Therapeutic Antioxidant Supplementation

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging

Amlodipine for Myocardial Iron in Thalassemia

An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months

A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product

Assessment of Iron Deposition in Major Organs of Hemodialysis Patients